These bacteria can also affect the bioavailability of folate by altering its form or binding to it
Remember, this is just an example, and your individual titration schedule may vary based on your healthcare provider's recommendations and your tolerance to retatrutide

According to the UK SmPC, the most common side effects include: Nausea (very common, affecting more than 1 in 10 people): Usually most pronounced during the first few weeks of treatment and often diminishes with continued use Diarrhoea (common, affecting up to 1 in 10 people): Typically mild to moderate in severity Vomiting (common): More frequent at higher doses Constipation (common): May occur alongside other gastrointestinal effects Abdominal pain or discomfort (common): Relatively frequent during treatment initiation Decreased appetite (very common): An expected effect related to the medication's action Dyspepsia/indigestion (common): May contribute to discomfort after eating Beyond gastrointestinal effects, other recognised adverse reactions include injection site reactions (redness, itching, or swelling at the subcutaneous injection site), fatigue , and dizziness
In fact, real world studies indicate these GI adverse events develop in between 40-70% of GLP-1 treated patients
Retatrutide Dosing Principles Current retatrutide dosing follows a gradual dose-escalation approach to help reduce gastrointestinal side effects as the body adjusts to treatment
Most Rho products have a serving size of approximately one teaspoon per day